DGTL Trademark

Trademark Overview

On Monday, December 5, 2016, a trademark application was filed for DGTL with the United States Patent and Trademark Office. The USPTO has given the DGTL trademark a serial number of 87258070. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 24, 2025. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The DGTL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, containing electronic chips which transmit information about drug ingestion by the patient
dgtl

General Information

Serial Number87258070
Word MarkDGTL
Filing DateMonday, December 5, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 24, 2025
Registration Number5515690
Registration DateTuesday, July 10, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, containing electronic chips which transmit information about drug ingestion by the patient

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo
JP
Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo
JP

Trademark Events

Event DateEvent Description
Friday, March 10, 2017NON-FINAL ACTION WRITTEN
Thursday, December 8, 2016NEW APPLICATION ENTERED
Friday, December 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 8, 2017ASSIGNED TO EXAMINER
Friday, March 10, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 10, 2017NON-FINAL ACTION E-MAILED
Monday, September 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 11, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 22, 2017SUSPENSION LETTER WRITTEN
Friday, September 22, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, September 22, 2017LETTER OF SUSPENSION E-MAILED
Thursday, November 2, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, November 14, 2017ASSIGNED TO LIE
Wednesday, November 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, December 10, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, December 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, December 10, 2017FINAL REFUSAL WRITTEN
Sunday, December 10, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, December 10, 2017FINAL REFUSAL E-MAILED
Tuesday, May 8, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, May 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 8, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 10, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 24, 2025CANCELLED SEC. 8 (6-YR)
Tuesday, July 10, 2018REGISTERED-SUPPLEMENTAL REGISTER
Monday, May 28, 2018APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, June 1, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED

Related Keywords

dgtl system disorders pharmaceutical nervous diseases central treatment preparations about drug